Copenhagen Life Science Summit
October 8-9
With a predominant focus on human health, the forthcoming European life science strategy will be an example of
a forward-looking policy that intend to harness the poten<al of innova<on and new technologies while upholding
the core principles of universal access to high-quality care – a hallmark of healthcare in Europe.
With the Compe<<veness Compass, the EU Commission has set a new poli<cal direc<on in which research and
innova<on is at the heart of boos<ng European compe<<veness to ensure sustainable prosperity, aiming to
develop and produce tomorrow's technologies – made in Europe innova<on. The Draghi Report highlights the life
science industry, encompassing both pharmaceu<cals and medical devices, as an example of what the EU can
achieve in technology and innova<ve product development.
On October 8-9, Rigshospitalet and Healthcare Denmark will host Copenhagen Life Science Summit as part of
Denmark's EU Presidency (July 1 - December 31, 2025), which will be included in the official conference
programme during the Presidency, focusing on the life science sector in a European context.
Copenhagen Life Science Summit will explore the state of the current EU health ecosystem in a global context
highligh<ng the role for a strong ecosystem approach to European coopera<on between industry, academia,
public health authori<es and pa<ents. The summit will contribute to the promo<on of Europe as a leading life
science region, where new innova<ve health solu<ons are to the benefit of pa<ents and the European health
systems.
The forthcoming EU Strategy for Life Sciences adopts an approach where “life sciences” as a term is broadly
understood as the study of living systems, from microorganisms, plants, animals and human beings to
ecosystems. It encompasses sectors from pharmaceu<cals to agriculture, energy, food and feed. The strategy will
iden<fy key challenges and opportuni<es to speed up the safe development, deployment and uptake of life
sciences-based innova<on, including to support the digital and green transi<ons of our society and economy. In
this context Copenhagen Life Science Summit focuses specifically on life sciences in rela<on to human health. It
includes research, innova<on, commercializa<on, scale up and implementa<on in pharmaceu<cals,
biotechnology and medical technology as well as AI and other data driven and digitally enabled health care
solu<on.
Copenhagen Life Science Summit aims to facilitate broad stakeholder discussions on a number of thema<c topics
with the objec<ve to shape policy discussions and the EU Strategy for Life Sciences:
• On October 8, Rigshospitalet will host a high-level conference day: “Invest, Innovate, Collaborate, Elevate:
Strategic Perspec<ves for an Innova<ve and Compe<<ve European Life Sciences Ecosystem" that will discuss
and shape policy recommenda<ons in the context of the EU Strategy for Life Sciences. The conference will
focus on transla<onal research and clinical trials, life science innova<on ecosystems, uptake of innova<ve
health solu<ons and interdisciplinary infrastructures for transforma<ve life science R&I.
On October 8, Healthcare Denmark will host a standing dinner recep<on in Copenhagen City Hall.
• On October 9, Healthcare Denmark will host a high-level conference day: "Life Science: A Catalyst for
European Compe<<veness" that will discuss how the European life science sector will be a catalyst for
compe<<veness with a close link to the EU Compass. The conference will focus on how Europe, through
public-private partnerships, can enhance compe<<veness and aaain strategic autonomy.
1
Preliminary Programme
Wednesday October 8
Invest, Innovate, Collaborate, Elevate: Strategic Perspec7ves for an Innova7ve and
Compe77ve European Life Sciences Ecosystem
Venue: Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen
Time Content Speakers
8:30 Arrival, registra<on
and networking
09:00 Welcome and • Welcome by Rasmus Møgelvang, CEO, Rigshospitalet and Lars
fireside discussion Gaardhøj, Chairman, Capital Region of Denmark.
• Fireside discussion by Margrethe Vestager and Enrico Le@a
(tbc)
Moderator: Di@e Brasso Sørensen, Deputy Director, Think Tank
EUROPA
09:30 Panel discussion State of the current EU health ecosystem in a global context
Moderated by: Di@e Brasso Sørensen, Deputy Director, Think
Tank EUROPA
• Elizabeth Macintyre, President, Biomedical Alliance in
Europe
• Nathalie Moll, CEO, EFPIA (tbc)
• Oliver Bisazza, CEO, MedTech Europe (tbc)
• Ernst Kuipers, Vice President (Research), Nanyang
Technological University, Singapore; and Prev. Minister of
Health, Welfare and Sport of the Netherlands
• Marco Greco, President of European Pa<ents Forum (tbc)
10:15 IntroducMon to break-out discussion
by Di@e Brasso Sørensen, Deputy Director, Think Tank EUROPA
10:30 Coffee break
11:00 Walk to Roundtable
discussions
2
11:15 Roundtable RTD 1: Strengthening applied transnaMonal and clinical research
discussions By Chair, CrisMna Messa, former Minister of University and
Research, Italy; and Co-chair, Malene Fischer, Research Director,
Rigshospitalet.
RTD 2: BoosMng the innovaMon of the European life science
industry
By Chair, Prof. Chantal Mathieu, KU Leuven (tbc); and Co-chair,
David Dreyer Lassen, Rector, University of Copenhagen.
RTD3: SupporMng the uptake and implementaMon of medical
technologies and health care soluMons
By Chair, Heyo Kroemer, CEO, Charité (tbc); and Co-chair, Rasmus
Møgelvang, CEO, Rigshospitalet.
RTD 4: Securing EU as a world leader in personalised medicine
and prevenMon
By Chair, Jens Habermann, CEO, BBMRI-ERIC (tbc); and Co-chair:
BeZna Lundgren, CEO, Danish Na<onal Genome Center (tbc).
RTD 5: Addressing European regulatory challenges
By Chair, Enrico Le@a, IE University’s School of Poli<cs, Economics
and Global Affairs (tbc); and Co-chair Ida Sofie Jensen, CEO, Lif.
12:45 Walk to lunch area
13:00 Lunch & networking
14:00 Panel debate How to create a world class European Ecosystem in life sciences
Moderator: Di@e Brasso Sørensen, Deputy Director, Think Tank
EUROPA
• David Dreyer Lassen, Rector, Copenhagen University
• Thomas Hoffmann, Director, Technical University Munich,
Innova<on District Munich (tbc)
• Rasmus Møgelvang, CEO, Rigshospitalet, Innova<on District
Copenhagen
• TBA
14:30 Pre- • Applied translaMon and clinical research, by chair
recommenda<ons • Cross-sectoral partnerships and innovaMon districts, by chair
from Roundtable • AdopMng efficient innovaMve soluMons while eliminaMng low
discussions benefit health care, by chair
3
• A world leader in personalised medicine and prevenMon.
How to make the most of data sharing, digitalisaMon, and
the use of AI, by chair
• Addressing European regulatory challenges, by chair
15:20 Short break
15:40 Keynote • Mario Draghi, former President of European Central Bank &
Author of the Future European Compe<<veness Report (tbc)
16:00 High level panel Moderator: Di@e Brasso Sørensen, Deputy Director, Think Tank
debate EUROPA
• Ekatarina Zaharieva, Commissioner for Startups, Research,
and Innova<on, European Commission (tbc)
• ChrisMna Egelund, Minister for Higher Educa<on & Science,
Denmark
• European minister of health
• Rasmus Møgelvang, CEO, Rigshospitalet
16:30 End of conference
4
Wednesday October 8
Life Science: A Catalyst for European Compe77veness
Venue: Copenhagen City Hall, Raadhuspladsen 1, Copenhagen
Time Content Speakers
RecepMon at Copenhagen City Hall
17.30 Arrival,
registra<on and
networking
18.00 Welcome Lars Weiss, Lord Mayor, Copenhagen
18.10 Opening remarks Sophie Løhde, Minister for the Interior and Health, Denmark
18.30 Networking
dinner
20.00 End of recep<on
Thursday October 9
Life Science: A Catalyst for European Compe77veness
Venue: Mærsk Tower, Copenhagen University, Blegdamsvej 3B, Copenhagen N
Time Content Speakers
08.00 Arrival,
registra<on and
networking
09.00 Welcome and David Dreyer Lassen, Rector, University of Copenhagen
opening remarks & Lykke Friis, Director, Think Tank EUROPA
09.15 Opening Keynote Unlocking Europe’s PotenMal: A Life Sciences Strategy for Prosperity
and Health
• Stéphane Séjourné, Execu<ve Vice-President for Prosperity and
Industrial Strategy, European Commission (TBC)
The opening keynote will present the Commission’s vision for
strengthening Europe’s life sciences sector, detailing key policy
5
ini<a<ves under the Strategy for Life Sciences and the
Compe<<veness Compass.
09.35 Keynote Losing Ground? Challenges for Europe’s Life Sciences Sector in the
Global Race for InnovaMon
• Elizabeth Kuiper, Associate Director and Head of the Social
Europe & Well-Being Programme, European Policy Centre
The keynote will assess the core drivers of Europe’s compe<<veness
in life sciences and iden<fy future policy challenges for the EU.
09.55 Panel Debate Back in the Lead: How to Design a European Industrial Policy for
Public Health and InnovaMon
Moderated by: Lykke Friis, Director, Think Tank EUROPA
• Ekaterina Zaharieva, Commissioner for Startups, Research, and
Innova<on, European Commission (TBC)
• Stefan Oelrich, President, European Federa<on of
Pharmaceu<cal Industries and Associa<on (TBC)
• Mónica García Gómez, Minister of Health, Spain (TBC)
• CEO, Novo Nordisk (TBC)
• Dolors Montserrat, MEP; Member of Commiaee on the
Environment, Climate and Food Safety (ENVI), European
Parliament (TBC)
The panel will debate the priori<es for EU industrial policy by
exploring the risks and poten<al of tools such as public investment,
policy reform, and joint procurement to drive innova<on in life
sciences while advancing European public health objec<ves.
10.40 Coffee Break
11.10 Fireside chat Aligning Public Goals with Corporate Growth: Lessons from the
Nordic Experience
Moderated by: Lykke Friis, Director, Think Tank EUROPA
• Lars Rasmussen, Chair of the Board for Coloplast and WS
Audiology; Chair of the Danish Life Science Council
This session will present the lessons learned from the Nordic
approach to public-private partnerships and explore how these
strategies could be scaled at the European level.
6
11.25 Panel Debate Public-Private Partnerships: A Catalyst for European
CompeMMveness and Health?
Moderated by: Lykke Friis, Director, Think Tank EUROPA
• Jennifer Carroll MacNeill, Minister for Health, Ireland (TBC)
• KersMn Jorna, Director-General for DG Internal Market, Industry,
Entrepreneurship and SMEs (DG GROW), European Commission
(TBC)
• Charl Van Zyl, CEO, H. Lundbeck
• SMne Bosse, MEP, Vice-Chair on the Commiaee on Public Health
(SANT), European Parliament (TBC)
The panel will examine the role of public-private partnerships in
fostering life sciences innova<on and strengthening healthcare.
Speakers will discuss how Europe can build more effec<ve na<onal
and cross-border collabora<ons between the public and private
sectors.
12.10 Networking Lunch
13.10 Keynote Why life science must be at the heart of Europe’s industrial strategy
to drive innovaMon, economic resilience, and public health
• Morten Bødskov, Minister for Industry, Business and Financial
Affairs, Denmark
13.30 Panel Debate Unlocking the Societal Value of InnovaMon: Shaping the Future of
Resilient, Sustainable and InnovaMve Healthcare in Europe
Moderated by: Di@e Brasso Sørensen, Deputy Director, ThinkTank
EUROPA
• Sandra Gallina, Director-General for DG for Health and Food
Safety (DG SANTE), European Commission
• Søren Nedergaard, CPO - Porpolio, People & Partnerships, Novo
Nordisk Founda<on
• Teresa Graham, CEO, Roche Pharmaceu<cal
• Marco Greco, President, European Pa<ents Forum (TBC)
The conversa<on will assess how strategic investments in life
sciences can strengthen healthcare systems across Europe through
economic growth and improved pa<ent outcomes.
7
14.15 Keynote Aligning Public Goals with Corporate Growth: Lessons from Europe
• Marc Ferracci, Minister for Industry and Energy, France (TBC)
14.30 Panel debate How to Boost Private Investment in Start-ups and Scale-ups: The
Role of RegulaMon and Capital Market Reform
Moderated by: Di@e Brasso Sørensen, Deputy Director, ThinkTank
EUROPA
• Gelsomina VigloZ, Vice President, European Investment Bank
(TBC)
• Jens Nielsen, CEO, BioInnova<on Ins<tute Founda<on,
Copenhagen
• Kim Jørgensen (To be announced)
• Rafaele Tordjman, Founder and CEO, Jeito Capital (TBC)
• Pascal Canfin, MEP, Member of the Commiaee on the
Environment, Climate and Food (ENVI); and the Commiaee of
Public Health (SANT), European Parliament (TBC)
This session will debate how the EU can bridge the private
investment gap in life science research and innova<on – in par<cular
what regulatory reforms are needed to unlock private funding and
how the EU can steer capital markets towards socially beneficial
investments.
15.15 Coffee Break
15.45 Panel Debate Spreading the Gains of CompeMMveness: Enhancing Access to
InnovaMve Healthcare Across the EU
Moderated by: Di@e Brasso Sørensen, Deputy Director, ThinkTank
EUROPA
• Anca Toma, Execu<ve Director, European Pa<ents Forum (TBC)
• VlasMmil Válek, Deputy Prime Minister and Minister of Health,
Czech Republic (TBC)
• Benjamin Roche@e, Vice President, Global Regulatory Affairs,
Coloplast
• Audrey Duval, Execu<ve Vice President of Corporate Affairs,
Sanofi (TBC)
• Radan Kanev, MEP, Member of the Commiaee on the
Environment, Climate and Food (ENVI), European Parliament
(TBC)
8
The panel will discuss how the EU’s industrial strategy should be
accompanied by measures to improve equitable access to innova<ve
treatments and ensure that investments in new life sciences hubs
deliver benefits across all member states, for example through
regulatory reform, financing condi<onali<es, stronger coordina<on,
or joint procurement.
16.30 Closing Remarks Moving Forward: Next Steps for Europe
• Lars Løkke Rasmussen, Minister for Foreign Affairs, Denmark
(TBC)
The closing remarks will reflect on key takeaways from the
conference and highlight ac<onable next steps for policymakers to
reinforce Europe’s leadership in life sciences.
16.45 End of
conference
16.45 Closing Recep<on
18.00 End of Closing Recep<on
9
SAVE THE DATE:
COPENHAGEN LIFE SCIENCE SUMMIT
October 8-9 2025 | Copenhagen, Denmark
Join us for Copenhagen Life Science Summit, a two-day high-level conference - part of
Denmark’s EU Presidency 2025 - hosted by Rigshospitalet and Healthcare Denmark,
taking place in Copenhagen on October 8-9 2025.
The high-level conference will bring together academia, decision-makers, public health
organisations, industry, and patient organisations from across EU27+, creating an
international forum for the European life Science ecosystem to meet, exchange insights,
and engage in discussions on the European Strategy for Life Sciences. The conference
will explore the state of the current EU health and life science ecosystem, highlight the
need for a strong, integrated European ecosystem, and create recommendations for the
European Life Science Strategy and framework for research and innovation.
Together, we will explore how Europe can advance its position as a leading life science
region – ensuring our competitiveness and contributing to more resilient, innovative health
systems that benefit patients across Europe.
The two-day programme:
• On October 8, Rigshospitalet will host the conference Invest, Innovate, Collaborate,
Elevate: Strategic Perspectives for an Innovative and Competitive European Life
Sciences Ecosystem on-site at Rigshospitalet.
In the evening, Healthcare Denmark will host a standing dinner reception at
Copenhagen City Hall.
• On October 9, Healthcare Denmark will host the conference Life Science: A Catalyst
for European Competitiveness at Maersk Tower, Copenhagen University.
Please mark your calendars now! In July 2025, when Denmark will hold the Presidency of
the Council of the European Union, official invitations and registration details will be
shared.
For further information and to view the preliminary program, kindly visit the official
webpage here: http://www.copenhagenlifesciencesummit.dk/
Copenhagen Life Science Summit is financially supported by the European Commission;
the Danish Ministry for Industry, Business and Financial Affairs; the Danish Ministry for
Higher Education and Science; and Novo Nordisk Foundation.
Saatja:
[email protected]
Saaja: "Info - SOM" <
[email protected]>
Teema: Save-the-date invitation to the Ministry of Social Affairs of Estonia to Copenhagen Life Science Summit, October 8-9, 2025
Kuupäev: 2025-06-11 13:31
Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.
Dear Minister of Social Affairs of Estonia, Karmen Joller,
On behalf of Denmark’s Presidency of the Council of the European Union, it
is with great pleasure that Rigshospitalet, Healthcare Denmark and our
partners extend a save-the-date invitation for the upcoming EU-conference
Copenhagen Life Science Summit. The conference will be held on October
8-9, 2025, in Copenhagen, Denmark.
Attached to this email, you will find your personal save-the-date
invitation and the preliminary programme. A formal invitation will follow
in due course.
Should you be unable to attend, we kindly invite you to delegate your
participation to your Deputy Secretary or another high-level
representative from your ministry. Please inform us accordingly if the
invitation is forwarded.
We are delighted to share that a number of distinguished speakers and
guests have already confirmed their participation, and we sincerely hope
to count you among them.
For more details, please visit the official conference website:
http://www. <http://www.copenhagenlifesciencesummit.dk/>
copenhagenlifesciencesummit.dk/
Should you have any questions or require further information, please do
not hesitate to contact us.
Kind regards,
Marie and Camilla
Antoinette Marie van de Vijver Jørgensen
Senior Advisor
<mailto:
[email protected]>
[email protected]
<tel:+4553777950> +45 53 77 79 50
DK Odense M, 5230 | Forskerparken 10Y
DK Copenhagen N, 2200 | BioInnovation Institute, Ole Maaløes Vej 3
<http://www.healthcaredenmark.dk> www.healthcaredenmark.dk
Camilla Simpson
International Affairs Advisor
M (+45) 2114 0731
@ <mailto:
[email protected]>
[email protected]
Rigshospitalet – Denmark’s largest University Hospital
Section 11.41
Esther Møllers Vej 1, Entrance 11, 4. floor
2100 Copenhagen
<http://www.rigshospitalet.dk/> www.rigshospitalet.dk